RxDoctor Payments DataLook up a doctor →

Katrina Jones Harris

Family · Montgomery, ALNPI 1316491046

Payments from drug & device makers

$18,097in general payments, 2019–2025

Across 624 payments — averaging $29.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AstraZeneca$1K
  • Amgen$1K
  • plus $9K from 47 others

What the payments were for

  • Food & beverage$18,097100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,097 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$12,869
Medicare patients
89
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin110$117,582
OzempicSemaglutide75$90,052
RybelsusSemaglutide46$86,592
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$51,818
MounjaroTirzepatide28$36,414
TrulicityDulaglutide31$33,602
PrezcobixDarunavir/Cobicistat11$31,485
DescovyEmtricitabine/Tenofov Alafenam11$28,135
JanuviaSitagliptin Phosphate15$24,583
Repatha SureclickEvolocumab27$23,585
EliquisApixaban23$22,666
FarxigaDapagliflozin Propanediol13$21,544
LinzessLinaclotide20$20,770
MyrbetriqMirabegron13$17,533
Janumet XrSitagliptin Phos/Metformin Hcl15$16,724

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,477$176,645121 claims
Boehringer IngelheimJardiance$275$117,582110 claims
Lilly USA, LLCMounjaro, Trulicity$1,277$70,01659 claims
GSKTrelegy Ellipta$790$51,81855 claims
MerckJanuvia, Janumet Xr$136$41,30730 claims
Johnson & JohnsonPrezcobix, Xarelto$581$39,91223 claims
GileadDescovy$288$28,13511 claims
AstraZenecaFarxiga, Symbicort$1,151$24,84127 claims
PfizerEliquis$693$22,66623 claims
AbbVieLinzess$2,115$20,77020 claims
Astellas Pharma US IncMyrbetriq$101$17,53313 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$71$1,24290 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.

Other family in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →